Blacklisting of Aveo Pharmaceuticals and Banning of Tapentadol and Carisoprodol Combination – Tafrodol or Royal 225
A company named Aveo Pharmaceuticals, based in the outskirts of Mumbai, managed by Vinod Sharma is involved in the production, sale and exportation of a range of addiction pills containing a harmful mix of Tapentadol (a powerful opioid), and Carisoprodol, a banned muscle relaxant with addictive properties that can cause overdose, or death. The mix […]
Public Alert No. 04/2025 – Public Alert on the Illegal Exportation and Sale of Opioids to West African Countries by Aveo Pharmaceuticals
The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public of an investigational report from BBC revealing that an Indian pharmaceutical company Aveo Pharmaceuticals is manufacturing unlicensed, highly addictive opioids and exporting them illegally to some West African countries including Ghana, Nigeria, and Cote D’Ivoire, where they are constituting a […]
Public Alert No. 03/2025 – Alert on the Sale of Counterfeit/Falsified Petsow Starnicillin (Ampicillin) 500mg found in Cameroon and Central African Republic
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the sale and distribution of falsified PETSOW STARNICILLIN 500mg purportedly manufactured by Petsow Laboratories Limited. This falsified product was reportedly circulated in Cameroon and Central African Republic. The original and registered products are STARNICILLIN (500mg) with NAFDAC Reg. No. […]
Public Alert No. 02/2025 – Illegal Distribution and Sale of Substandard and Falsified (SF) Knowit Insulin Syringe 40 IU 29g X 1/2
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the illegal circulation and marketing of a substandard and falsified Knowit Insulin Syringe 40 IU 29g X 1/2 in Nigeria. The Association of Community Pharmacists of Nigeria (ACPN) raised concern regarding the ongoing use of 40 IU/ML insulin syringes […]
Public Alert No. 01/2025 – NAFDAC has Discontinued Registration of Multi-Dose Artemether /Lumefantrine Dry Powder for Oral Suspension
The National Agency for Food and Drug Administration and Control (NAFDAC) would like to inform the public that it has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension. This decision was made due to the instability of the reconstituted formulations, which can lead to a loss of efficacy over time. This […]
